Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 11/2019

01-11-2019 | Rectal Cancer | Special Section: Rectal Cancer

Current controversy, confusion, and imprecision in the use and interpretation of rectal MRI

Authors: Marc J. Gollub, Chandana Lall, Neeraj Lalwani, Michael H. Rosenthal

Published in: Abdominal Radiology | Issue 11/2019

Login to get access

Abstract

There has been a rapid increase in the utilization of MRI in rectal cancer staging in the USA essentially replacing endorectal ultrasound and mimicking the trend in Europe seen in the 1990s and 2000s. Accompanying this trend, there is a demand, and recognized need, for greater precision and clarification of confusing, misunderstood and poorly understood concepts, facts, statements and nomenclature regarding rectal cancer and the use of pelvic MRI for diagnosis. As such, this Review, part evidence-based and part expert opinion, will attempt to elucidate and clarify several concepts the authors have encountered in 25 years of imaging rectal cancer, focusing on MRI.
Literature
1.
Siegel, R.L., et al., Colorectal Cancer Incidence Patterns in the United States, 1974-2013. J Natl Cancer Inst, 2017. 109(8).
2.
Glimelius, B., et al., Mesorectal fascia instead of circumferential resection margin in preoperative staging of rectal cancer. J Clin Oncol, 2011. 29(16): p. 2142-3.CrossRefPubMed
3.
4.
Nougaret, S., et al., The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the "DISTANCE"? Radiology, 2013. 268(2): p. 330-44.CrossRefPubMed
5.
Horvat, N., I. Petkovska, and M.J. Gollub, MR Imaging of Rectal Cancer. Radiol Clin North Am, 2018. 56(5): p. 751-774.CrossRefPubMed
6.
Quirke, P., et al., Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet, 1986. 2(8514): p. 996-9.
7.
Group, M.S., Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology, 2007. 243(1): p. 132-9.CrossRef
8.
Glimelius, L.B.B., The ‘good’, the ‘bad’, and the ‘ugly’ rectal cancers. Acta Oncologica, 2008. 47( 1): p.5-8.CrossRefPubMed
9.
Nagtegaal, I.D., et al., Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol, 2002. 26(3): p. 350-7.CrossRefPubMed
10.
Birbeck, K.F., et al., Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg, 2002. 235(4): p. 449-57.CrossRefPubMedPubMedCentral
11.
Shihab, O.C., et al., Magnetic resonance imaging-detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excision. Br J Surg, 2010. 97(9): p. 1431-6.CrossRefPubMed
12.
Stedman, T.L., Stedman’s medical dictionary, 28th edn. 2006, Philadelphia: Lippincott Williams & Wilkins
13.
Netter, F.H., Atlas of human anatomy. Sixth edition. ed. 2014, Philadelphia, PA: Saunders/Elsevier.
14.
Chung, E., et al., Accuracy of pelvic MRI in measuring tumor height in rectal cancer patients with or without preoperative chemoradiotherapy. Eur J Surg Oncol, 2018.
15.
Dujovny, N., R.M. Quiros, and T.J. Saclarides, Anorectal anatomy and embryology. Surg Oncol Clin N Am, 2004. 13(2): p. 277-93.CrossRefPubMed
16.
Nigro, N.D., et al., Combined therapy for cancer of the anal canal. Dis Colon Rectum, 1981. 24(2): p. 73-5.CrossRefPubMed
17.
Shihab, O.C., et al., Can a novel MRI staging system for low rectal cancer aid surgical planning?ω Dis Colon Rectum, 2011. 54(10): p. 1260-4.CrossRefPubMed
18.
Bamba, Y., M. Itabashi, and S. Kameoka, Preoperative evaluation of the depth of anal canal invasion in very low rectal cancer by magnetic resonance imaging and surgical indications for intersphincteric resection. Surg Today, 2012. 42(4): p. 328-33.CrossRefPubMed
19.
Scala, D., et al., Laparoscopic intersphincteric resection: indications and results. Updates Surg, 2016. 68(1): p. 85-91.CrossRefPubMed
20.
Kim, J.H., et al., High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol, 2004. 52(1): p. 78-83.CrossRefPubMed
21.
Brown, G., et al., Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology, 2003. 227(2): p. 371-7.CrossRefPubMed
22.
Fujita, S., et al., Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial. Ann Surg, 2017. 266(2): p. 201-207.CrossRefPubMed
23.
Ogura, A., et al., Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer. J Clin Oncol, 2018: p. JCO1800032.
24.
Blazic I, P.S., Konishi T, Campbell N, Garcia-Aguilar J, Gollub MJ., Clinical Impact of Lateral Lymph Nodes at Pelvic MRI in Patients with Rectal Cancer. ECR2019 Accepted abstract, 2018.
25.
Oh, H.K., et al., Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Ann Surg Oncol, 2014. 21(7): p. 2280-7.CrossRefPubMed
26.
Chand, M., et al., Mucinous carcinoma of the rectum: a distinct clinicopathological entity. Tech Coloproctol, 2014. 18(4): p. 335-44.CrossRefPubMed
27.
Hugen, N., et al., Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous Carcinoma. Ann Surg Oncol, 2015. 22(8): p. 2669-76.CrossRefPubMed
28.
Oberholzer, K., et al., Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation. Int J Radiat Oncol Biol Phys, 2012. 82(2): p. 842-8.CrossRefPubMed
29.
Yu, S.K., et al., Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy. Eur J Cancer, 2014. 50(5): p. 920-7.CrossRefPubMed
30.
Beets-Tan, R.G.H., et al., Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol, 2017.
31.
Gollub, M.J., et al., Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017. Abdom Radiol (NY), 2018.
32.
Barbaro, B., et al., The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease. Br J Radiol, 2017. 90(1069): p. 20150836.CrossRefPubMed
33.
Kim, M.J., et al., Accuracy in differentiation of mucinous and nonmucinous rectal carcinoma on MR imaging. J Comput Assist Tomogr, 2003. 27(1): p. 48-55.CrossRefPubMed
34.
Beets, G.L., et al., A new paradigm for rectal cancer: Organ preservation: Introducing the International Watch & Wait Database (IWWD). Eur J Surg Oncol, 2015. 41(12): p. 1562-4.CrossRefPubMed
35.
Habr-Gama, A., et al., Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys, 2014. 88(4): p. 822-8.CrossRefPubMed
36.
Habr-Gama, A., et al., Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg, 2004. 240(4): p. 711-7; discussion 717-8.
37.
van der Valk, M.J.M., et al., Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet, 2018. 391(10139): p. 2537-2545.CrossRefPubMed
38.
39.
Slater, A., et al., Distance between the rectal wall and mesorectal fascia measured by MRI: Effect of rectal distension and implications for preoperative prediction of a tumour-free circumferential resection margin. Clin Radiol, 2006. 61(1): p. 65-70.CrossRefPubMed
40.
Ye, F., et al., JOURNAL CLUB: Preoperative MRI Evaluation of Primary Rectal Cancer: Intrasubject Comparison With and Without Rectal Distention. AJR Am J Roentgenol, 2016. 207(1): p. 32-9.CrossRefPubMed
41.
Stijns, R.C., et al., The influence of endorectal filling on rectal cancer staging with MRI. Br J Radiol, 2018. 91(1089): p. 20180205.CrossRefPubMed
42.
Schrag, D., et al., Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance). Clin Trials, 2019: p. 1740774518824539.
43.
Vliegen, R.F., et al., Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful? Radiology, 2005. 234(1): p. 179-88.CrossRefPubMed
44.
Corines, M.J., et al., Gadolinium-Based Contrast Agent During Pelvic MRI: Contribution to Patient Management in Rectal Cancer. Dis Colon Rectum, 2018. 61(2): p. 193-201.CrossRefPubMedPubMedCentral
45.
Gollub, M.J., et al., Does gadolinium-based contrast material improve diagnostic accuracy of local invasion in rectal cancer MRI? A multireader study. AJR Am J Roentgenol, 2015. 204(2): p. W160-7.CrossRefPubMedPubMedCentral
46.
Gollub, M.J., et al., Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. Eur Radiol, 2012. 22(4): p. 821-31.CrossRefPubMed
47.
Gollub, M.J., et al., Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer. Eur Radiol, 2017. 27(4): p. 1605-1612.CrossRefPubMed
48.
Gollub, M.J., et al., Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer. Eur Radiol, 2018.
49.
Gollub, M.J., et al., Prognostic aspects of DCE-MRI in recurrent rectal cancer. Eur Radiol, 2013. 23(12): p. 3336-44.CrossRefPubMed
50.
Dijkhoff, R.A.P., et al., Value of DCE-MRI for staging and response evaluation in rectal cancer: A systematic review. Eur J Radiol, 2017. 95: p. 155-168.CrossRefPubMed
51.
Mandard, A.M., et al., Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer, 1994. 73(11): p. 2680-6.PubMed
52.
Dworak, O., L. Keilholz, and A. Hoffmann, Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis, 1997. 12(1): p. 19-23.CrossRefPubMed
53.
Rodel, C., et al., Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol, 2005. 23(34): p. 8688-96.CrossRefPubMed
54.
55.
Trakarnsanga, A., et al., Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment. J Natl Cancer Inst, 2014. 106(10).
56.
Patel, U.B., et al., Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol, 2011. 29(28): p. 3753-60.CrossRefPubMed
57.
Sclafani, F., et al., Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. Br J Cancer, 2017. 117(10): p. 1478-1485.CrossRefPubMedPubMedCentral
58.
Patel, U.B., et al., Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann Surg Oncol, 2012. 19(9): p. 2842-52.CrossRefPubMed
59.
Battersby, N.J., et al., A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial. Trials, 2017. 18(1): p. 394.CrossRefPubMedPubMedCentral
60.
van der Paardt, M.P., et al., Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology, 2013. 269(1): p. 101-12.CrossRefPubMed
61.
Maas, M., et al., Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment. Ann Surg Oncol, 2015. 22(12): p. 3873-80.CrossRefPubMedPubMedCentral
62.
Gollub, M., Pelvic MRI after Induction Chemotherapy and Before Long-Course Chemoradiation Therapy for Rectal Cancer: What are the Imaging Findings? European Radiology, 2019.
63.
Sakuyama, N., et al., Histological differences between preoperative chemoradiotherapy and chemotherapy for rectal cancer: a clinicopathological study. Pathol Int, 2016. 66(5): p. 273-80.CrossRefPubMed
Metadata
Title
Current controversy, confusion, and imprecision in the use and interpretation of rectal MRI
Authors
Marc J. Gollub
Chandana Lall
Neeraj Lalwani
Michael H. Rosenthal
Publication date
01-11-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 11/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-01996-3

Other articles of this Issue 11/2019

Abdominal Radiology 11/2019 Go to the issue

Special Section: Rectal Cancer

The use of PET/MRI for imaging rectal cancer

Special Section: Rectal Cancer

Complete mesocolic excision and central vascular ligation for right colon cancer: an introduction for abdominal radiologists

Special Section: Rectal Cancer

Pathologist’s perspective on primary rectal cancer

Special Section: Rectal Cancer

Genetics of rectal cancer and novel therapies: primer for radiologists

Special Section: Rectal Cancer

Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer

Special Section: Rectal Cancer

Primary and post-chemoradiotherapy staging using MRI in rectal cancer: the role of diffusion imaging in the assessment of perirectal infiltration

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits